Laminin interactions with the apoproteins of acute-phase HDL: Preliminary mapping of the laminin binding site on serum amyloid A

Amyloid

Volumn 6, Issue 1, 1999, Pages 37-47

  Ancsin, John B ^a   Kisilevsky, Robert ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

AA amyloidogenesis; ApoSAA; Binding site; CNBr peptides; Laminin

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LAMININ; SERUM AMYLOID A;

AMINO ACID SEQUENCE; AMYLOIDOSIS; ARTICLE; BINDING AFFINITY; BINDING SITE; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION;

EID: 0032967093     PISSN: 13506129     EISSN: None     Source Type: Journal    
DOI: 10.3109/13506129908993286     Document Type: Article

References (59)

1. Husby G, Marhaug G, Dowton B, Sletten K and Sipe JD (1994). Serum amyloid (SAA): Biochemistry, genetics and the pathogenesis of AA amyloid. Amyloid 1, 119-137
2. Steel DM and Whitehead AS (1994). The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunology Today 15, 81-88
3. Uhlar CM, Burgess CJ, Sharp PM and Whitehead AS (1994). Evolution of serum amyloid A (SAA) protein superfamily. Genomics 19, 228-235
4. Jensen LE, Hiney MP, Shields DC, Uhlar, CM, Lindsay, AJ, and Whitehead AS (1997). Acute phase proteins in Salmonids - Evolutionary analyses and acute phase response. J. Immunol. 158, 384-392
5. Meek RL and Benditt EP (1989). Rat tissue express serum amyloid A protein-related mRNAs. Proc. Natl. Acad. Sci. USA 86, 1890-1894
6. Lowell CA, Stearman RS and Morrow JF (1986). Transcriptional regulation of serum amyloid A gene expression. J. Biol. Chem. 261, 8453-8461
7. Goldberger G, Bing DH, Sipe JD, Rits M and Colten HR (1987). Transcriptional regulation of genes encoding the acute-phase proteins CRP, SAA and C3. J. Immunol. 138, 3967-3971
8. McAdam KPWJ and Sipe JD (1976). Murine model for human secondary amyloidosis: Genetic variability of the acutephase serum protein SAA response to endotoxins and casein. J. Exp. Med 144, 1121-1127
9. Benditt EP and Eriksen N (1977). Amyloid protein SAA is associated with high density lipoprotein from human serum. Proc. Natl. Acad. Sci. USA 74, 4025-4028
10. Coetzee GA, Strachan AF, van der Westhuyzen DR, Hoppe HC, Jeenah MS and de Beer FC (1986). Serum amyloid-containing human high density lipoprotein 3. Density, size and apolipoprotein composition. J. Biol. Chem. 261, 9644-9651
11. Tape C, Tan R, Nesheim, M, and Kisilevsky, R (1988). Direct evidence for circulating apoSAA as the precursor of tissue AA amyloid deposits. Scand. J. Immunol. 28, 317-324
12. Husebbek A, Skogen B, Husby G, and Marhaug, G (1985). Transformation of amyloid precursor SAA to protein AA and incorporation in amyloid fibrils in-vivo. Scand. J. Immunol. 21, 283-287
13. Meek RL, Hoffman JS, Benditt EP (1986). Amyloidogenesis. One serum amyloid A isotype is selectively removed from the circulation. J. Exp. Med. 163, 499-510
14. Kisilevsky R (1990). Heparan sulfate proteoglycans in amyloidogenesis: An epiphenomenon. A unique factor, or the tip of a more fundamental process. Lab. Invest. 63, 589-591
15. McCubbin WD, Kay CM, Narindrasorasak S and Kisilevsky R (1988). Circular-dichroism studies on two murine serum amyloid A proteins. Biochem J. 256, 775-783
16. de Beer MC, de Beer FC, McCubbin WD, Kay CM and Kindy MS (1993). Structural prerequisites for serum amyloid A fibril formation. J. Biol. Chem. 268, 20606-20612
17. Kisilevsky R, Lemieux LJ, Fraser PE, Kong X, Hultin PG and Szarek WA (1995). Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: Implications for Alzheimer's disease. Nature Medicine 1, 143-147
18. Fraser PE, Nguyen JT, Chin DT and Kirschner DA (1992). Effects of sulphate ions on Alzheimer-beta/A4 peptide assemblies-implications for amyloid fibril-proteoglycan interactions. J. Neurochem. 59, 1531-1540
19. Priola SA and Caughey B (1994). Inhibition of scrapie-associated PrP accumulation. Probing the role of glycosaminoglycans in amyloidogenesis. Mol. Neurobiol. 8, 113-120
20. Kelly JW and Lansbury PT (1994). A chemical approach to elucidate the mechanism of transthyretin and β-protein amyloid fibril formation. Amyloid 1, 186-205
21. Brunden KR, Richter-Cook NJ, Chaturvedi N, and Frederickson RC (1993). pH-dependent binding of synthetic β -amyloid peptides to glycosaminoglyeans. J. Neurochem. 61, 2147-2154
22. Castillo GM, Ngo C, Cummings J, Wight TN, and Snow AD (1997). Perlecan binds to the β-amyloid proteins (Aβ) of Alzheimer's disease, accelerates Aβ fibril formation, and maintains Aβ fibril stability. J. Neurochem. 69, 2452-2465
23. Snow AD, Kinsella MG, Parks E, Sekiguchi RT, Miller JD, Kimata K, and Wight TN (1995). Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the β-amyloid protein of Alzheimer's disease. Arch. Biochem. Biophys. 320, 84-95
24. Leveugle B, Ding WH, Laurence F, Dehouck MP, Scanemeo A, Cecchelli R, and Fillit H (1998). Heparin oligosaccharides that pass the blood brain barrier inhibit β-amyloid precursor protein secretion and heparin binding to β-amyloid peptide. J. Neurochem. 70, 736-744
25. Leveugle B, Scanemeo A, Ding W, and Fillit H (1994). Binding of heparan sulfate glycosaminoglycan to β-amyloid peptide: Inhibition by potentially therapeutic polysulfated compounds. NeuroReport 5, 1389-1392
26. Narindrasorasak S, Lowery D, Gonzalez-DeWhitt P, Poorman RA, Greenberg BD and Kisilevsky R (1991). High affinity interactions between the Alzheimer's beta-amyloid percursor proteins and the basement membrane form of heparan sulfate proteoglycan. J. Biol. Chem. 266, 12878-12883
27. Narindrasorasak S, Lowery DE, Altman RA, Gonzalez-DeWhitt P, Greenberg BD and Kisilevsky R (1992). Characterization of high affinity binding between laminin and Alzheimer's disease amyloid precursor proteins. Lab. Invest. 67, 643-652
28. Narindrasorasak S, Altman RA, Gonzalez-DeWhitt P, Greenberg BD and Kisilevsky R (1995). An interaction between basement membrane and Alzheimer's precursor proteins suggests a role in the pathogenesis of Alzheimer's disease. Lab. Invest. 72, 272-282
29. Ancsin JB and Kisilevsky R (1997). Characterization of high affinity binding between laminin and the acute-phase protein, serum amyloid A. J. Biol. Chem. 272, 406-413
30. Ancsin JB and Kisilevsky R (1996). Laminin interactions important for basement membrane assembly are promoted by zinc and implicate laminin zinc finger-like sequences. J. Biol. Chem. 271, 6845-6851
31. Nichols WC, Dwulet FE, Liepnieks J, and Benson MD (1988). Variant apolipoprotein AI as a major constituent of a human hereditary amyloid. Biochem. Biophys. Res. Commun. 156, 762-768
32. Turnell WG, Sarra R, Glover ID, Baum JO and Caspi D (1986). Secondary structure prediction of human SAA!. Presumptive identification of calcium and lipid binding sites. Mol. Biol. Med. 3, 387-407
33. Axelrad MA, Kisilevsky R, Willmer J, Chen SJ and Skinner M (1982). Further characterization of amyloid enhancing factor. Lab. Invest. 47, 139-146
34. Havel RJ, Eder HA, and Bragdon JH (1955). The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. clin. Invest. 34, 1345-1353
35. Osborne JC (1986). Delipidation of plasma lipoproteins. Meth, Enzymol. 128, 213-222
36. Goldsmith MR, Rattner EC, Koehler MM, Balikov SR and Bock SC (1979). Two-dimensional electrophoresis of smallmolecular-weight proteins. Anal. Biochem. 99, 33-40
37. Laemmli UK (1970). Cleavage of structural proteins during the assembly of the heads of bacteriophage T4. Nature 227, 680-685
38. de Beer MC, Beach CM, Shedlofsky SI and de Beer FC (1991). Identification of a novel serum amyloid A protein in BALB/c mice. Biochem J. 280, 45-49
39. Meek RL, Eriksen N and Benditt EP (1992). Murine serum amyloid A3 is a high density apolipoprotein and is secreted by macrophages. Proc. Natl. Acad. Sci. USA 89, 7949-7952
40. Yamamoto KI and Migita S (1985). Complete primary structure of two major murine serum amyloid A proteins deduced from cDNA sequences. Proc. Natl. Acad. Sci. USA 82, 2915-2919
41. Lowell CA, Potter DA, Stearman RS, Morrow JF (1986). Structure of the murine serum amyloid A gene family. Gene conversion. J Biol. Chem. 261, 8442-8452
42. Preciado-Patt L, Levartowsky D, Prass M, Hershkoviz R, Lider O, and Fridkin M (1994). Inhibtion of cell adhesion to glycoproteins of the extracellular matrix by peptides corresponding to serum amyloid A - towards understanding the physiological role of an enigmatic protein. Eur. J. Biochem. 223, 35-42
43. Woodrow SI, Gore J, Kisilevsky R and Young ID (1994). Type-IV collagen gene expression in experimental splenic AA amyloidosis. In: Amyloid and Amyloidosis, (Kisilevsky R, Benson MD, Frangione B, Gaudie J, Mickle TJ and Young ID eds.) New Jersey: The Parthenon Publishing Group, pp. 195-197
44. Ailles L, Kisilevsky R and Young ID (1993). Induction of perlecan gene expression precedes amyloid formation during experimental murine AA amyloidogenesis. Lab. Invest. 69, 443-448
45. Yurchenco PD and O'Rear JJ (1994). Basal lamina assembly. Curr. Opinion Cell Biol. 6, 674-681
46. Aumailley M (1995). Structure and supramolecular organization of basement membrane. Kidney Int. 47, 4-7
47. Sletten K, Westermark P and Natvig JB (1980). Senile cardiac amyloid is related to prealbumin. Scand. Immunol. 12, 503-506
48. Westermark P, Johnson KH, Westermark GT, Sletten K and Hayden DW (1986). Bovine amyloid protein AA: isolation and amino acid sequence analysis. Comp. Biochem. Physiol. 85B, 609-614
49. Rossevatn K, Andresen PK, Sletten K, Husebekk A, Husby G, Nordstoga K, Johnson KH, Westermark GT and Westermark P (1992). The complete amino acid sequence of bovine serum amyloid protein A (SAA) and of subspecies of the tissue-deposited amyloid Fibril protein A. Scand. J. Immunol. 35, 217-224
50. Beach CM, deBeer MC, Sipe JD, Loose LD and deBeer FC (1992). Human serum amyloid A protein. Biochem J. 282, 615-620
51. Preciado-Patt L, Hershkoviz R, Fridkin M and Lider O (1996). Serum amyloid A binds specific extracellular matrix glycoproteins and induces the adhesion of resting CD4 T cells. J. Immunol. 156, 1189-1195
52. Hershkoviz R, Preciado-Patt L, Lider O, Fridkin M, Dastych J, Metcalfe DD and Mekori YA, (1997). Extracellular matrix-anchored serum amyloid A preferentially induces mast cell adhesion. Am. J. Physiol. 273, C179-C187
53. Perlmutter LS, Chui HC, Saperia D, and Athanikar J. (1990). Microangiopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer's disease. Brain Res 508:13-19.
54. Perlmutter LS, and Chui HC. (1990). Microangiopathy, the vascular basement membrane and Alzheimer's disease - a review. Brain Res Bull. 24:677-686.
55. Perlmutter LS, Barron E, Saperia D, and Chiu HC. (1991). Association between vascular basement membrane componenls and the lesions of Alzheimer's disease. J Neurosci Res. 30:673-681.
56. Perlmutter LS, (1994) Microvascular pathology and vascular basement membrane components in Alzheimer's disease. Mol Neurobiol. 9:33-40.
57. Kawahara E. (1989). The role of fibronectin in the development of experimental amyloidosis - evidence of immunohistochemical codistribution and binding property with scrum amyloid protein - A. Am J Pathol 134:1305-1314.
58. Westermark GT, Norling B, and Westermark P. (1991). Fibronectin and basement membrane components in renal amyloid deposits in patients with primary and secondary amyloidosis. Clin Exp Immunol 86:150-156.
59. Bronfman FC, Alvarez A, Morgan C, and Inestrosa NC (1998). Laminin blocks the assembly of wild type Aβ and the Dutch variant peptides into Alzheimer's fibrils. Amyloid Int. J. Exp. Clin. Invest. 5, 16-23.